BioDuro’s Scientific Advisory Board brings together distinguished industry leaders with deep expertise in drug discovery, development, and pharmaceutical innovation.
Their guidance supports BioDuro’s commitment to scientific excellence, strategic growth, and delivering high-quality solutions for biotech and pharmaceutical partners.
Former Global Head of Small Molecule Research, Medicinal Chemistry, Roche
Dr. Andrew Thomas is an entrepreneur focused on transforming impactful innovation in the healthcare sector. He was formerly the Global Head of Small Molecule Research, Medicinal Chemistry at Roche. More recently, he has managed two investment funds focused on Swiss technology growth companies. During his career he has published more than 100 patents, peer-reviewed journals and books, with his most notable Roche success being his team’s invention and development of Evrysdi for the treatment of spinal muscular atrophy.
Former Vice President, Discovery Chemistry and Technology, AbbVie
Dr. Stevan Djuric is President of Discovery Chemistry and Technology Consulting LLC. Previously he served as Vice President of Discovery Chemistry and Technology at AbbVie, where he led the global Medicinal Chemistry Leadership Team and discovery chemistry organization. During his career at Abbott and AbbVie, he advanced multiple drug discovery programs into clinical development and contributed to the development of Zotarolimus and other therapeutic innovations. Dr. Djuric has authored more than 180 scientific publications and patents and serves on several scientific and editorial advisory boards.
